KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Asset Utilization Ratio: 2011-2024

Historic Asset Utilization Ratio for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2024 value amounting to 0.04.

  • TherapeuticsMD's Asset Utilization Ratio rose 80.87% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year increase of 80.87%. This contributed to the annual value of 0.04 for FY2024, which is 120.29% up from last year.
  • According to the latest figures from FY2024, TherapeuticsMD's Asset Utilization Ratio is 0.04, which was up 120.29% from 0.02 recorded in FY2023.
  • TherapeuticsMD's Asset Utilization Ratio's 5-year high stood at 0.54 during FY2022, with a 5-year trough of 0.01 in FY2021.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.04 (2024), whereas its average is 0.20.
  • In the last 5 years, TherapeuticsMD's Asset Utilization Ratio spiked by 3,572.66% in 2022 and then crashed by 96.38% in 2023.
  • TherapeuticsMD's Asset Utilization Ratio (Yearly) stood at 0.29 in 2020, then tumbled by 94.94% to 0.01 in 2021, then spiked by 3,572.66% to 0.54 in 2022, then plummeted by 96.38% to 0.02 in 2023, then spiked by 120.29% to 0.04 in 2024.